Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 1992: Vol 46 Index

12 Pages·1992·3.5 MB·English

507
Volume 46, 1992
Author index
A Beuscart R — See Bailly D et al, 419
Biljanovic-Paunovic L — See Pavlovic-Kentera V et al,
37
Abel U, Chemotherapy of advanced epithelial cancer - a
critical review, 439 Bizzini B — See Carelli C et al, 149 — See Zagury JF
Aboud-Pirak E — See Carelli C et al, 149 et al, 343 — See Picard O et al, 353 — ***,
Carlotti M, Fattal German M, Anti-infectious
Achour A — See Carelli C et al, 149 — See Zagury JF
effect of C Granulosum-derived P40 immuno-
et al, 343 — See Picard O et al, 353 — See Willer
modulator given by aerosolization and intranasal
A et al, 359
instillation, 491
Alard P — See Lantz O et al, 85
Blanco ML — See Pérez-Gallardo L et al, 173
Alonso K, Pontiggia P, Nardi C, Sabato A, Cuppone
Blandin N — See Bailly D et al, 419
Curto F, Systemic hyperthermia in the treatment
of HIV-related Kaposi's sarcoma. A phase I Blazsek I, Innate chaos: I. The origin and genesis of
study, 21 complex morphologies and homeotic regulation,
219
Angeloni P — See Novelli G et al, 169
Boitard C — See Timsit J et al, 71
Boranic M — See Krizanac-Bengez L et al, 367
B
Borioni R — See Garofalo R et al, 401
Bortin MM — See Sobocinski KA et al, 57
Bailly D, Servant D, Blandin N, Beuscart R, Parquet
PJ, Effects of beta-blocking drugs in alcohol Bouchacha M, Salles JP, Fallet M, Frileux P, Cugnenc
withdrawal: a double-blind comparative study PH, Barbier JP, Effect of pinaverium bromide on
with propranolol and diazepam, 419 jejunal motility and colonic transit time in healthy
humans, 161
Balézs C — See Molnar I et al, 121
Boyer O — See Picard O et al, 353
Bamberger T, Masson I, Mathieu J, Chauvelot-
Moachon L, Giroud JP, Florentin I, Nitric oxide Bravo-Cuellar A — See Ortiz GG et al, 115
mediates the depression of lymphoproliferative
Brienza S — See Mathé G et al, 17
responses following burn injury in rats, 495
Bringuier AF, Séébold-Choqueux C, Moricard Y,
Barbier JP — See Bouchacha M et al, 161
Simmons DJ, Milhaud G, Labat ML, T-
Bartmann U — See Nigro G et al, 155 lymphocyte control of HLA-DR blood monocyte
differentiation into neo-fibroblasts. Further
Battista C — See Listoria S et al, 453
evidence of pluripotential secreting functions of
Bernard J -— See Carelli C et al, 149 — See Zagury JF
HLA-DR monocytes, involving not only collagen
et al, 343 — See Picard O et al, 353
but also uromodulin, amyloid-6 peptide, a-
Bessone G — See Morra L et al, 393 fetoprotein and carcinoembryonic antigen, 91
508 Author index
Burny A — See Carelli C et al, 149 — See Picard O et de la Mora-Rivas G — See Ortiz GG et al, 115
al, 353 — See Zagury JF et al, 343
De Santis L — See Novelli G et al, 169
Degos L, All-trans retinoic acid (ATRA) therapeutical
C
effect in acute promyelocytic leukemia, 201
Desgranges C — See Picard O et al, 353
Callebeau I — See Zagury JF et al, 343
Djukanovic LJ — See Pavlovic-Kentera V et al, 37
Cantalloube H — See Zagury JF et al, 343
Donnet A, Dufour H, Graziani N, Grisoli F,
Caracd C — See Listoria S et al, 453 Minocycline and benign intracranial hypertension,
171
Cardenas-Ortega A — See Ortiz GG et al, 115
Carelli C — ***, Halbreich A, Bernard J, Bizzini B, Dousset’- B, Houssin D, Liver transplantation: the
Achour A, Zagury JF, Lebon P, Polliotti B, chalienges of the 1990s, 79
Folghera S, Laaroubi K, Aboud-Pirak E, Lowell Dubois G, Tapiero H, Variation of choline-substituted
G, Burny A, Picard O, dZagury OD, lipid metabolism in doxorubicin-resistant
Immunogenicity of combined anti-HIV and anti- leukemia cells, 485
depressive vaccine preparations, 149 — See
Duesberg PH, The role of drugs in the origin of AIDS,
Zagury JF et al, 343 — See Picard O et al, 353
3
Carlotti M — See Picard O et al, 353 — See Bizzini B
Dufour H — See Donnet A et al, 171
et al, 491
Carlucci F — See Tabucchi A et al, 25 — ***,
Tabucchi A, Consolmagno E, Tagliaferri P, E
Porcelli B, Marinello E, Leoncini R, Pagani R,
Levels and variability of purine nucleotids in
Eriguchi M — See Fujii Y et al, 405
normal human lymphocytes, 109
Escanero JF — See Pérez-Gallardo L et al, 173
Castelli L — See Listoria S et al, 453
Esposito G — See Listoria S et al, 453
Charpentier B — See Lantz O et al, 85 — ***, Current
problems in organ transplantation, 53
F
Chatenoud L — See Timsit J et al, 71
Chauvelot-Moachon L — See Bamberger T et al, 495
Fall L — See Zagury JF et al, 343 — See Picard O et
Clemons GK — See Pavlovic-Kentera V et al, 37
al, 353
Cochat P — See Favrot M et al, 211
Fallet M — See,Bouchacha M et al, 161
Comaru-Schally AM — See Schally AV et al, 465
Fattal German M — See Bizzini B et al, 491
Consolmagno E — See Carlucci F et al, 109
Favrot M, Frappaz D, Saltel P, Cochat P, Therapy of
Cooper EH, Forbes MA, Hancock AK, Parker D,
“high risk' myelodysplastic syndromes with an
Laurence V, Serum bone alkaline phosphatase
association of low-dose lira-C, retinoic acid and
and CA 549 in breast cancer with bone
1,23-dihydroxyvitamin D3, 211
metastases, 31
Feria-Velasco A — See Ortiz GG et al, 115
Cosme MH — See Zagury JF et al, 343
Florentin I — See Bamberger T ef al, 495
Cugnenc PH — See Bouchacha M et al, 161
Folghera S — See Carelli C et al, 149
Cuppone Curto F — See Alonso K et al, 21
Forbes MA — See Cooper EH et al, 31
Frappaz D — See Favrot M et al, 211
D
Fridman WH — See Tartour E et al, 473
Dallapiccola B — See Novelli G et al, 169 Frileux P — See Bouchacha M et al, 161
Fujii Y, Hasumi K, Nakamura H, Takahama Y,
Author index 509
Shimizu H, Sugawara I, Eriguchi M, Sekiguchi L
M, Characterization of a murine monoclonal
antibody, 5D-4, reacting with pancreatic cancers
Laaroubi K — See Carelli C et al, 149 — See Willer A
and islets of Langerhans, 405
et al, 359
Labat ML — See Bringuier AF et al, 91
G
Lachgar A — See Zagury JF et al, 343 — See Picard O
et al, 353 — See Willer A et al, 359
Garofalo R, Borioni R, Garofalo RLLA, Lavanga G,
Lantz O, Alard P, Charpentier B, Allogenic recognition
Mathé G, Radical tumor excision and cosmetic
in 1992, 85
balance in the surgical treatment of breast
carcinoma: biquadrantectomy, 401 Laurence V — See Cooper EH et al, 31
Garofalo RLLA — See Garofalo R et al, 401 Lavanga G — See Garofalo R et al, 401
Gennarelli M — See Novelli G et al, 169 Lebon P — See Carelli C et al, 149
Gil-Delgado M — See Mathé G et al, 17 Legendre C — See Timsit J et al, 71
Giroud JP — See Bamberger T et al, 495 Leoncini R — See Carlucci F et al, 109
Goldstein AL — See Willer A et al, 359 Lezaic V — See Pavlovic-Kentera V et al, 37
Gonzalez-Barcena D — See Schally AV et al, 465 Listoria S, Panza N, Esposito G, Vergara E, Castelli L,
Caracd C, Battista C, Pacilio G, Salvatore M,
Graziani N — See Donnet A et al, 171
Management of patients with ovarian cancer using
Grisoli F — See Donnet A et al, 171 monoclonal antibodies, 453
Lépez Lozano JJ — See Pérez Trullen JM et al, 375
H
Lowell G — See Carelli C et al, 149
Lurhuma Z — See Picard O et al, 353
Halbreich A — See Carelli C et al, 149
Hancock AK — See Cooper EH et al, 31
M
Harada N — See Shimoda K et al, 337
Hasumi K — See Fujii Y et al, 405 Manganaro M — See Nigro G et al, 155
Horowitz MM — See Sobocinski KA et al, 57 Marinello E — See Carlucci F et al, 109
Houssin D — See Dousset B et al, 79 Marinello F — See Tabucchi A ef al, 25
Hozumi M — See Okabe-Kado J et al, 193 Marisavljevic D — See Pavlovic-Kentera V et al, 37
Huang Y — See Waxman S et al, 183 Marotti T — See Krizanac-Bengez L et al, 367
Masson I — See Bamberger T et al, 495
Mathé G — ***, Is the AIDS virus responsible for the
disease?, 1 — *** , Meyer P, Brienza S, Gil-
Delgado M, Orbach-Arbouys S, Itzhaki M,
Issing W — See Zagury JF et al, 343
Retrospective study correlating clinical infectious
Itzhaki M — See Mathé G et al, 17
history and peripheral blood T-cell
subpopulations in cancer, GvH and HIV+
patients, 17 — ***, Transplantation, immunity,
K
tolerance and grafts. Dempster, Hasek “et les
autres’, 49 — See Garofalo R et al, 401, — Is the
Krizanac-Bengez L, Boranic M, Testa NG, Marotti T, "war against cancer" lost?, 433
Effect of enkephalins on bone marrow cells, 367
Mathieu J — See Bamberger T et al, 495
Mathiot C — See Tartour E et al, 473
510 Author index
Mattia S — See Nigro G et al, 155 Okamura S — See Shimoda K et al, 337
Mbika JP — See Zagury JF et al, 343 — See Picard O Omori F — See Shimoda K et al, 337
et al, 353 — See Willer A et al, 359
Orbach-Arbouys S — See Mathé G et al, 17 — See
Mela GS — See Morra L et al, 393 Ortiz GG et al, 115
Meyer P — See Mathé G et al, 17 Ortiz GG, de la Mora-Rivas G, Cardenas-Ortega A,
Orbach-Arbouys S, Bravo-Cuellar A, Feria-
Milhaud G — See Bringuier AF et al, 91
Velasco A, Hepatotoxicity induced by a single ip
Moccia F — See Morra L et al, 393
injection of ruthenium red, 115
Modrego Pardo PJ — See Pérez Trullen JM et al, 375
Molnar I, Balazs C, TSH binding site structures in P
human eye muscle fractions identified by using
covalent-crosslinking, 121
Pacilio G — See Listoria S et al, 453
Moricard Y — See Bringuier AF et al, 91
Pagani R — See Tabucchi A et al, 25 — See Carlucci F
Mornon JP — See Zagury JF et al, 343
et al, 109
Morra L, Moccia F, Ponassi I, Bessone G, Mela GS,
Palazzo L — See Roseau G et al, 133
Ponassi GA, In vitro growth of erythroid
progenitor cells (BFU-E) and production of burst- Panza N — See Listoria S et al, 453
promoting activity -BPA) by T lymphocytes in Paolaggi JA — See Roseau G et al, 133
patients with myelodysplastic syndromes, 393
Parker D — See Cooper EH et al, 31
Mouroux J, Richelme H, Surgical endoscopy in
Parquet PJ — See Bailly D et al, 419
thoracic surgery, 139
Pavlovic-Kentera V, Clemons GK, Biljanovic-Paunovic
L, Marisavljevic D, Lezaic V, Pokrajac M,
N Djukanovic LJ, Serum erythropoietin levels in
hemodialysed patients after administration of
recombinant human erythropoietin, 37
Nakamura H — See Fujii Y et al, 405
Pelletier G, Non-surgical management of bile duct
Nardi C — See Alonso K et al, 21
stones, 143
Nastasi V — See Nigro G et al, 155
Pellion F — See Zagury JF et al, 343
Naylor PH — See Willer A et al, 359
Pérez Trullen JM, Modrego Pardo PJ, Vasquez André
Nigro G, Bartmann U, Mattia S, Nastasi V, Torre A,
M, Lépez Lozano JJ, Bromezan-induced
Manganaro M, Perrone T, Tucciarone L, Acute dystonia, 375
hepatitis in childhood: virological, immunological
Pérez-Gallardo L, Blanco ML, Soria H, Escanero JF,
and clinical aspects, 155
Displacement of rifampcin bound to serum
Niho Y — See Shimoda K et al, 337
proteins by addition of levamisole, 173
Nihrane A — See Willer A et al, 359
Perrone T — See Nigro G et al, 155
Novelli G, Gennarelli M, De Santis L, Angeloni P,
Picard O — See Carelli C et al, 149 — See Willer A et
Dallapiccola B, Inosine-containing primers in
al, 359 — ***, Bernard J, Lachgar A, Fall L,
human papillomavirus detection by polymerase
Carlotti M, Achour A, Carelli C, Salaun JJ,
chain reaction, 169
Mbika JP, Lurhuma Z, Desgranges C, Boyer O,
Burny A, Zagury JF, Bizzini B, Zagury D,
O Removal of GP160 induced bio-hazards for a safe
AIDS vaccine candidate, 353
Pokrajac M — See Pavlovic-Kentera V et al, 37
Okabe-Kado J, Hozumi M, Identity of differentiation
inhibiting factor for mouse myeloid leukemia cells Polliotti B — See Carelli C et al, 149
with Nm23/nucleoside diphosphate kinase, 193
Ponassi GA — See Morra L et al, 393
Author index 511
Ponassi I — See Morra L et al, 393 Soria H — See Pérez-Gallardo L et al, 173
Pontiggia P — See Alonso K et al, 21 Sugawara I — See Fujii Y et al, 405
Porcelli B — See Carlucci F et al, 109
Sullivan SJ, Allotransplantation of canine pancreatic
Puy H, Thyroid hormone extraction by plasma islets, 385
exchange: a study of extraction rate, 413
T
R
Tabucchi A — See Carlucci F et al, 109 — ***,
Ramazzotti A — See Tabucchi A et al, 25 Carlucci F, Ramazzotti A, Re MC, Marinello F,
Rubino M, Pagani R, Analysis of purine
Re MC — See Tabucchi A et al, 25
nucleotides in lymphocytes from healthy subjects
Richelme H — See Mouroux J et al, 139
and AIDS patients, 25
Rimm AA — See Sobocinski KA et al, 57
Tagliaferri P — See Carlucci F et al, 109
Roseau G, Palazzo L, Paolaggi JA, Endoscopic
Takahama Y — See Fujii Y et al, 405
ultrasonography in colorectal diseases, 133
Rubino M — See Tabucchi A et al, 25 Tapiero H — See Dubois G et al, 485
Tartour E, Mathiot C, Fridman WH, Current status of
Interleukin-2 therapy in cancer, 473
Testa NG — See Krizanac-Bengez L et al, 367
Sabato A — See Alonso K et al, 21 Thoreau E — See Zagury JF et al, 343
Salaun JJ — See Picard O et al, 353
Timsit J, Legendre C, Chatenoud L, Boitard C,
Salles JP — See Bouchacha M et al, 161 Pancreas and islet cell transplantation in man, 71
Saltel P — See Favrot M et al, 211 Torre A — See Nigro G et al, 155
Salvatore M — See Listoria S et al, 453 Tucciarone L — See Nigro G et al, 155
Sarin PS — See Willer A et al, 359
Schally AV, Comaru-Schally AM, Gonzalez-Barcena V
D, Present status of agonistic and antagonistic
analogs of LH-RH in the treatment of advanced
prostatic cancer, 465 Vasquez André M — See Pérez Trullen JM et al, 375
Séébold-Choqueux C — See Bringuier AF et al, 91 Vergara E — See Listoria S et al, 453
Sekiguchi M — See Fujii Y et al, 405
Servant D — See Bailly D et al, 419 W
Sher BM — See Waxman S et al, 183
Sher M — See Waxman S et al, 183 Waxman S, Huang Y, Sher BM, Sher M, Enhancement
of differentiation and cytotoxicity of leukemia
Shimizu H — See Fujii Y et al, 405
cells by combinations of fluorinated pyrimidines
Shimoda K, Okamura S, Harada N, Omori F, Niho Y, and differentiation inducers: development of DNA
Serum granulocyte colony-stimulating factor double-strand breaks, 183
levels in umbilical cord blood of normal full-term
Willer A, Achour A, Mbika JP, Laaroubi K, Lachgar
neonates, 337
A, Nihrane A, Picard O, Naylor PH, Sarin PS,
Simmons DJ — See Bringuier AF et al, 91
Goldstein AL, Zagury D, Cell-mediated immunity
Sobocinski KA, Horowitz MM, Rimm AA, Bortin MM, against HGP-30, a group-specific peptide of HIV
Current status of allogeneic bone marrow p17 in individuals infected with the AIDS virus,
transplantation, 57 359
512 Author index
Cantalloube H, Bernard J, Lachgar A, Fall L,
Achour A, Mbika JP, Cosme MH, Pellion F,
Issing W, Carelli C, Bizzini B, Thoreau E,
Zagury D — See Carelli C et al, 149 — See Zagury JF Callebeau I, Burny A, Mornon JP, Zagury D,
et al, 343 — See Picard O et al, 353 — See Willer Critical sites: a semantic approach to protein se-
A et al, 359 quences. Application to the HIV-1 envelope
molecule, 343 — See Picard O et al, 353
Zagury JF — See Carelli C et al, 149 — ***,
Volume 46, 1992
Keyword index
A phosphatase and CA 549 in breast cancer with
bone metastases, 31
all-trans retinoic acid — All-trans retinoic acid (ATRA) bone marrow — Current status of allogeneic bone
therapeutical effect in acute promyelocytic leuke- marrow transplantation, 57
mia, 201
bone marrow cell — Effect of enkephalins on bone
allograft — Current problems in organ transplantation, 53 marrow cells, 367
amyloid-f peptide — T-lymphocyte control of HLA- bone metastase — Serum bone alkaline phosphatase and
DR blood monocyte differentiation into neo-fi- CA 549 in breast cancer with bone metastases, 31
broblasts. Further evidence of pluripotential se- breast cancer — Serum bone alkaline phosphatase and
creting functions of HLA-DR monocytes, involv-
CA 549 in breast cancer with bone metastases, 31
ing not only collagen but also uromodulin, amy-
Bromazepan — Bromezan-induced dystonia, 375
loid-8 peptide, a-fetoprotein and carcinoembry-
onic antigen, 91 brucellosis — Displacement of rifampcin bound to
serum proteins by addition of levamisole, 173
anti-AIDS vaccine — Immunogenicity of combined
anti-HIV and anti-depressive vaccine burn injury — Nitric oxide mediates the depression of
preparations, 149 — Removal of GP160 induced lymphoproliferative responses following burn
bio-hazards for a safe AIDS vaccine candidate, injury in rats, 495
353 — Cell-mediated immunity against HGP-30, a
group-specific peptide of HIV p17 in individuals
C
infected with the AIDS virus, 359
anti-CD4 antibody — Removal of GP160 induced bio-
calcium-channel antagonist — Effect of pinaverium
hazards for a safe AIDS vaccine candidate, 353
bromide on jejunal motility and colonic transit
Automat (software) — Critical sites: a semantic
time in healthy humans, 161
approach to protein sequences. Application to the
HIV-1 envelope molecule, 343 cancer — Retrospective study correlating clinical infec-
tious history and peripheral blood T-cell subpopu-
lations in cancer, GvH and HIV+ patients, 17
B
carcinoma — Chemotherapy of advanced epithelial
cancer - a critical review, 439
benzodiazepine — Bromezan-induced dystonia, 375
chaos — Innate chaos: I. The origin and genesis of
bilestones — Non-surgical management of bile duct complex morphologies and homeotic regulation, 219
stones, 143
chemical mediator — Innate chaos: I. The origin and
biogenesis — Innate chaos: I. The origin and genesis of genesis of complex morphologies and homeotic
complex morphologies and homeotic regulation, 219 regulation, 219
bone alkaline phosphatase — Serum bone alkaline chemotherapy — Chemotherapy of advanced epithelial
514 Keyword index
cancer - a critical review, 439 E
colon — Endoscopic ultrasonography in _ colorectal
diseases, 133 — Effect of pinaverium bromide on ELISA — Serum granulocyte colony-stimulating factor
jejunal motility and colonic transit time in healthy levels in umbilical cord blood of normal full-term
humans, 161 neonates, 337
combination cytotoxic-differentiation therapy — En-
endoscopic ultrasonography — Endoscopic ultrasono-
hancement of differentiation and cytotoxicity of graphy in colorectal diseases, 133
leukemia cells by combinations of fluorinated
enhancing antibody — Removal of GP160 induced bio-
pyrimidines and differentiation inducers: devel-
hazards for a safe AIDS vaccine candidate, 353
opment of DNA double-strand breaks, 183
enkephalin — Effect of enkephalins on bone marrow
computer-assisted analysis — Critical sites: a semantic
cells, 367
approach to protein sequences. Application to the
HIV-1 envelope molecule, 343 erythropoietin — Serum erythropoietin levels in
hemodialysed patients after administration of re-
cord blood — Serum granulocyte colony-stimulating
combinant human erythropoietin, 37
factor levels in umbilical cord blood of normal
full-term neonates, 337 Epstein-Barr virus — Acute hepatitis in childhood: vi-
rological, immunological and clinical aspects, 155
Critic (software) — Critical sites: a semantic approach
to protein sequences. Application to the HIV-1
envelope molecule, 343 F
cytomegalovirus — Acute hepatitis in childhood: vi-
rological, immunological and clinical aspects, 155
5-fluorouracil — Enhancement of differentiation and
cytosine arabinoside — Therapy of “high risk’ cytotoxicity of leukemia cells by combinations of
myelodysplastic syndromes with an association of fluorinated pyrimidines and differentiation induc-
low-dose lra-C, retinoic acid and 1,23-dihy- ers: development of DNA double-strand breaks, 183
droxyvitamin D3, 211
FUra — Enhancement of differentiation and cytotoxic-
ity of leukemia cells by combinations of fluori-
D nated pyrimidines and differentiation inducers:
development of DNA double-strand breaks, 183
differentiation — T-lymphocyte control of HLA-DR
G
blood monocyte differentiation into neo-fibro-
blasts. Further evidence of pluripotential secreting
functions of HLA-DR monocytes, involving not
G-CSF — Serum granulocyte colony-stimulating factor
only collagen but also uromodulin, amyloid-f
levels in umbilical cord blood of normal full-term
peptide, a-fetoprotein and carcinoembryonic an-
neonates, 337
tigen, 91
Graves ophtalmopathy — TSH binding site structures
differentiation inhibiting factor — Identity of
in human eye muscle fractions identified by using
differentiation inhibiting factor for mouse myeloid
covalent-crosslinking, 121
leukemia cells with Nm23/nucleoside diphosphate
GvH — Retrospective study correlating clinical infec-
kinase, 193
tious history and peripheral blood T-cell subpopu-
differentiation therapy — Sth International Congress
lations in cancer, GVH and HIV+ patients, 17
on Differentiation Therapy (Villasimius, Sardinia,
Italy, September 1992), 181-336
H
DNA break — Enhancement of differentiation and cyto-
toxicity of leukemia cells by combinations of
fluorinated pyrimidines and differentiation induc- H2 restriction — Allogenic recognition in 1992, 85
ers: development of DNA double-strand breaks, 183
hepatitis B virus — Acute hepatitis in childhood: vi-
drug-induced dystonia — Bromezan-induced dystonia, 375
rological, immunological and clinical aspects, 155
Keyword index 515
hepatotoxicity — Hepatotoxicity induced by a single ip homeosis — Innate chaos: I. The origin and genesis of
injection of ruthenium red, 115 complex morphologies and homeotic regulation, 219
HGP-30 — Cell-mediated immunity against HGP-30, a human eye muscle — TSH binding site structures in
group-specific peptide of HIV p17 in individuals human eye muscle fractions identified by using
infected with the AIDS virus, 359 covalent-crosslinking, 121
high performance liquid chromatography — Levels hyperthermia — Systemic hyperthermia in_ the
and variability of purine nucleotids in normal treatment of HIV-related Kaposi's sarcoma. A
human lymphocytes, 109 phase I study, 21
HIV — Systemic hyperthermia in the treatment of HIV-
related Kaposi's sarcoma. A phase I study, 21
HIV p17 — Cell-mediated immunity against HGP-30, a
group-specific peptide of HIV p17 in individuals
immunomodulator — Anti-infectious effect of C
infected with the AIDS virus, 359
Granulosum-derived P40 immunomodulator given
HIV patients — Retrospective study correlating clinical
by aerosolization and intranasal instillation, 491
infectious history and peripheral blood T-cell
immunosuppression — Immunogenicity of combined
subpopulations in cancer, GvH and HIV+
patients, 17 — Analysis of purine nucleotides in anti-HIV and anti-depressive vaccine prepara-
tions, 149 —- Current problems in organ trans-
lymphocytes from healthy subjects and AIDS
plantation, 53 — Nitric oxide mediates the de-
patients, 25
pression of lymphoproliferative responses follow-
HIV-1 Env gp160 protein — Removal of GP160 in-
ing burn injury in rats, 495
duced bio-hazards for a safe AIDS vaccine candi-
date, 353 immunotherapy — Current status of Interleukin-2
therapy in cancer, 473
HIV-1 envelope molecule — Critical sites: a semantic
approach to protein sequences. Application to the influenza — Anti-infectious effect of C Granulosum-
HIV-1 envelope molecule, 343 derived P40 immunomodulator’ given’ by
aerosolization and intranasal instillation, 491
HIV-1 peptide — Immunogenicity of combined anti-HIV
and anti-depressive vaccine preparations, 149 inosine — _ Inosine-containing primers in human
papillomavirus detection by polymerase chain
HIV-1 vaccine — Immunogenicity of combined anti-HIV and
reaction, 169
anti-depressive vaccine preparations, 149 — Removal of
GP160 induced bio-hazards for a safe AIDS vaccine interleukin — Current status of Interleukin-2 therapy in
candidate, 353 — Cell-mediated immunity against cancer, 473
HGP-30, a group-specific peptide of HIV p17 in indi-
intracranial hypertension — Minocycline and benign
viduals infected with the AIDS virus, 359
intracranial hypertension, 171
HL-60 cell — Enhancement of differentiation and cyto-
islet — Pancreas and islet cell transplantation in man, 71
toxicity of leukemia cells by combinations of
fluorinated pyrimidines and differentiation induc-
ers: development of DNA double-strand breaks, 183
HLA-DR neo-fibroblasts — T-lymphocyte control of
HLA-DR blood monocyte differentiation into neo-
jejunum — Effect of pinaverium bromide on jejunal mo-
fibroblasts. Further evidence of pluripotential se-
tility and colonic transit time in healthy humans, 161
creting functions of HLA-DR monocytes, involv-
ing not only collagen but also uromodulin, amy-
loid-8 peptide, a-fetoprotein and carcinoembry- K
onic antigen, 91
HMBA — Enhancement of differentiation and cytotox- K pneumoniae infection — Anti-infectious effect of C
icity of leukemia cells by combinations of fluori-
Granulosum-derived P40 immunomodulator given
nated pyrimidines and differentiation inducers:
by aerosolization and intranasal instillation, 491
development of DNA double-strand breaks, 183
Kaposi's sarcoma — Systemic hyperthermia in the treat-
516 Keyword index
ment of HIV-related Kaposi's sarcoma. A phase | N
study, 21
nitric oxide — Nitric oxide mediates the depression of
L lymphoproliferative responses following burn
injury in rats, 495
Nim23/nucleoside diphosphate kinase — Identity of
leucovorin — Enhancement of differentiation and cyto-
toxicity of leukemia cells by combinations of differentiation inhibiting factor for mouse myeloid
leukemia cells with Nm23/nucleoside diphosphate
fluorinated pyrimidines and differentiation induc-
ers: development of DNA double-strand breaks, kinase, 193
183 non-surgical treatment — Non-surgical management of
levamisole — Displacement of rifampcin bound to bile duct stones, 143
serum proteins by addition of levamisole, 173
LH-RH analog — Present status of agonistic and O
antagonistic analogs of LH-RH in the treatment of
advanced prostatic cancer, 465
opportunistic infections — Retrospective study
liver — Liver transplantation: the challenges of the correlating clinical infectious history and
1990s, 79
peripheral blood T-cell subpopulations in cancer,
lymphocyte — Analysis of purine nucleotides in GvH and HIV+ patients, 17
lymphocytes from healthy subjects and AIDS ovarian tumor — Management of patients with ovarian
patients, 25 cancer using monoclonal antibodies, 453
overview — Chemotherapy of advanced epithelial
M cancer - a critical review, 439
major histocompatibility complex (MHC) — Allogenic P
recognition in 1992, 85
MDR + leukemia cells — Variation of choline-substi-
papillomavirus — Inosine-containing primers in human
tuted lipid metabolism in doxorubicin-resistant papillomavirus detection by polymerase chain
leukemia cells, 485 reaction, 169
minocycline — Minocycline and benign intracranial hy- pediatric hepatitis — Acute hepatitis in childhood: vi-
pertension, 171 rological, immunological and clinical aspects, 155
MIPS data bank — Critical sites: a semantic approach peptide — Cell-mediated immunity against HGP-30, a
to protein sequences. Application to the HIV-1 group-specific peptide of HIV p17 in individuals
envelope molecule, 343 infected with the AIDS virus, 359
monoclonal antibody — Management of patients with
peripheral blood T-cells — Retrospective study corre-
ovarian cancer using monoclonal antibodies, 453 lating clinical infectious history and peripheral
motility — Effect of pinaverium bromide on jejunal blood T-cell subpopulations in cancer, GvH and
motility and colonic transit time in healthy HIV+ patients, 17
humans, 161 phosphatidylcholine — Variation of choline-substituted
myelodysplastic syndrome — Therapy of ~high risk’ lipid metabolism in doxorubicin-resistant leuke-
myelodysplastic syndromes with an association of mia cells, 485
low-dose lra-C, retinoic acid and 1,23-dihy- placenta — Serum granulocyte colony-stimulating
droxyvitamin D3, 211
factor levels in umbilical cord blood of normal
myeloid leukemia — Identity of differentiation full-term neonates, 337
inhibiting factor for mouse myeloid leukemia cells polymerase chain reaction — _ Inosine-containing
with Nm23/nucleoside diphosphate kinase, 193 primers in human papillomavirus detection by
polymerase chain reaction, 169